The ReCell suspension contains basal keratinocytes, melanocytes, fibroblasts and Langerhans cells.
The metabolically responsive epithelial cells migrate across the wound surface, leading to regeneration of skin of normal color and texture.
ReCellSpray-On Skin is used for burns, plastic, reconstructive and cosmetic procedures.
Pinderfields hospital plastic surgery principal investigator JeremyRawlins said this technique results in less pain for the patient, a smaller donor site, faster wound healing and better scar outcomes.
Avita Medical CEO William Dolphin said clinical studies have established that ReCell Spray-On skin regenerative technology, designed to harness the body’s ability to heal itself, provides significant benefits to the patient, surgeon and health care system.
